Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 202

1.

A study of the association between UGT1A1*28 variant allele of UGT1A1 gene and colonic phenotype of sporadic colorectal cancer.

Anon B, Perray C, Regnault D, Caulet M, Orain I, Godart B, Pages JC, Tallet A, Ouaissi M, Guyetant S, Barin-le Guellec C, Lecomte T.

Dig Liver Dis. 2018 Dec 10. pii: S1590-8658(18)31271-4. doi: 10.1016/j.dld.2018.11.032. [Epub ahead of print]

PMID:
30583998
2.

FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.

Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul JL, Choné L, Francois E, Artru P, Biagi JJ, Lecomte T, Assenat E, Faroux R, Ychou M, Volet J, Sauvanet A, Breysacher G, Di Fiore F, Cripps C, Kavan P, Texereau P, Bouhier-Leporrier K, Khemissa-Akouz F, Legoux JL, Juzyna B, Gourgou S, O'Callaghan CJ, Jouffroy-Zeller C, Rat P, Malka D, Castan F, Bachet JB; Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group.

N Engl J Med. 2018 Dec 20;379(25):2395-2406. doi: 10.1056/NEJMoa1809775.

PMID:
30575490
3.

Resection of small bowel adenocarcinoma metastases: Results of the ARCAD-NADEGE cohort study.

Rompteaux P, Gagnière J, Gornet JM, Coriat R, Baumgaertner I, Lecomte T, Afchain P, Zaanan A, Pocard M, Bachet JB, Bonichon-Lamichhane N, Bouché O, Faucheron JL, Forestier J, Lecaille C, Manfredi S, Tougeron D, Terrebonne E, Chehimi M, Villing AL, Sarda C, Legoux JL, Benamouzig R, Aparicio T.

Eur J Surg Oncol. 2018 Nov 22. pii: S0748-7983(18)32011-0. doi: 10.1016/j.ejso.2018.11.012. [Epub ahead of print]

PMID:
30501999
4.

A melanosis coli associated with a large flat adenoma of the cecum.

Lecomte T, Chautard R, Orain I.

Clin Res Hepatol Gastroenterol. 2018 Nov 14. pii: S2210-7401(18)30222-5. doi: 10.1016/j.clinre.2018.10.006. [Epub ahead of print] No abstract available.

PMID:
30447908
5.

FOLFIRINOX as induction treatment in rectal cancer patients with synchronous metastases: Results of the FFCD 1102 phase II trial.

Bachet JB, Lucidarme O, Levache CB, Barbier E, Raoul JL, Lecomte T, Desauw C, Brocard F, Pernot S, Breysacher G, Lagasse JP, Di Fiore F, Etienne PL, Dupuis OJM, Aleba A, Lepage C, Taieb J; for FFCD 1102 investigators.

Eur J Cancer. 2018 Nov;104:108-116. doi: 10.1016/j.ejca.2018.09.006. Epub 2018 Oct 18.

PMID:
30343254
6.

EPIGIST: An observational real-life study on patients with metastatic gastrointestinal stromal tumors receiving imatinib.

Bouché O, Cesne AL, Rios M, Chaigneau L, Italiano A, Duffaud F, Lecomte T, Arsène D, Manfredi S, Aparicio T, Remy S, Isambert N, Collard O, Priou F, Bertucci F, Sambuc R, Bisot-Locard S, Bourges O, Chabaud S, Blay JY.

PLoS One. 2018 Sep 18;13(9):e0204117. doi: 10.1371/journal.pone.0204117. eCollection 2018.

7.

The prevalence of substance-induced psychotic disorder in methamphetamine misusers: A meta-analysis.

Lecomte T, Dumais A, Dugré JR, Potvin S.

Psychiatry Res. 2018 Oct;268:189-192. doi: 10.1016/j.psychres.2018.05.033. Epub 2018 May 17.

PMID:
30041133
8.

Acceptance and Commitment Therapy for Psychosis and Trauma: Investigating Links between Trauma Severity, Attachment and Outcome.

Spidel A, Daigneault I, Kealy D, Lecomte T.

Behav Cogn Psychother. 2018 Jul 17:1-14. doi: 10.1017/S1352465818000413. [Epub ahead of print]

PMID:
30012233
9.

Correction: Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.

Lièvre A, Ouine B, Canet J, Cartier A, Amar Y, Cacheux W, Mariani O, Guimbaud R, Selves J, Lecomte T, Guyetant S, Bieche I, Berger F, de Koning L.

Br J Cancer. 2018 Aug;119(3):387. doi: 10.1038/s41416-018-0130-x.

PMID:
29899390
10.

Overweight is associated to a better prognosis in metastatic colorectal cancer: A pooled analysis of FFCD trials.

Aparicio T, Ducreux M, Faroux R, Barbier E, Manfredi S, Lecomte T, Etienne PL, Bedenne L, Bennouna J, Phelip JM, François E, Michel P, Legoux JL, Gasmi M, Breysacher G, Rougier P, De Gramont A, Lepage C, Bouché O, Seitz JF; for FFCD investigators.

Eur J Cancer. 2018 Jul;98:1-9. doi: 10.1016/j.ejca.2018.03.031. Epub 2018 May 26.

11.

Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer.

Aparicio T, Bouché O, Francois E, Retornaz F, Barbier E, Taieb J, Kirscher S, Etienne PL, Faroux R, Khemissa Akouz F, El Hajbi F, Locher C, Rinaldi Y, Lecomte T, Lavau-Denes S, Baconnier M, Oden-Gangloff A, Genet D, Bedenne L, Paillaud E; for PRODIGE 20 investigators.

Eur J Cancer. 2018 Jul;97:16-24. doi: 10.1016/j.ejca.2018.03.030. Epub 2018 May 16.

PMID:
29777975
12.

Possible association of CAG repeat polymorphism in KCNN3 encoding the potassium channel SK3 with oxaliplatin-induced neurotoxicity.

Anon B, Largeau B, Girault A, Chantome A, Caulet M, Perray C, Moussata D, Vandier C, Barin-Le Guellec C, Lecomte T.

Cancer Chemother Pharmacol. 2018 Jul;82(1):149-157. doi: 10.1007/s00280-018-3600-1. Epub 2018 May 17.

PMID:
29774408
13.

Implementing cognitive behavioral therapy for psychosis: An international survey of clinicians' attitudes and obstacles.

Lecomte T, Samson C, Naeem F, Schachte L, Farhall J.

Psychiatr Rehabil J. 2018 Jun;41(2):141-148. doi: 10.1037/prj0000292. Epub 2018 May 3.

PMID:
29723013
14.

Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results.

Aparicio T, Bouché O, Taieb J, Maillard E, Kirscher S, Etienne PL, Faroux R, Khemissa Akouz F, El Hajbi F, Locher C, Rinaldi Y, Lecomte T, Lavau-Denes S, Baconnier M, Oden-Gangloff A, Genet D, Paillaud E, Retornaz F, François E, Bedenne L; for PRODIGE 20 Investigators.

Ann Oncol. 2018 Nov 1;29(11):2270. doi: 10.1093/annonc/mdx808. No abstract available.

15.

Psychotic disorders in sexually abused youth: A prospective matched-cohort study.

Bourgeois C, Lecomte T, Daigneault I.

Schizophr Res. 2018 Sep;199:123-127. doi: 10.1016/j.schres.2018.03.020. Epub 2018 Mar 13.

PMID:
29548761
16.

RAS mutation analysis in circulating tumor DNA from patients with metastatic colorectal cancer: the AGEO RASANC prospective multicenter study.

Bachet JB, Bouché O, Taieb J, Dubreuil O, Garcia ML, Meurisse A, Normand C, Gornet JM, Artru P, Louafi S, Bonnetain F, Thirot-Bidault A, Baumgaertner I, Coriat R, Tougeron D, Lecomte T, Mary F, Aparicio T, Marthey L, Taly V, Blons H, Vernerey D, Laurent-Puig P.

Ann Oncol. 2018 May 1;29(5):1211-1219. doi: 10.1093/annonc/mdy061.

PMID:
29438522
17.

Cognitive deficits in individuals with methamphetamine use disorder: A meta-analysis.

Potvin S, Pelletier J, Grot S, Hébert C, Barr AM, Lecomte T.

Addict Behav. 2018 May;80:154-160. doi: 10.1016/j.addbeh.2018.01.021. Epub 2018 Jan 31. Review.

PMID:
29407687
18.

Development and validation of an ELISA to study panitumumab pharmacokinetics.

Desvignes C, Passot C, Ternant D, Caulet M, Guérineau C, Lecomte T, Paintaud G.

Bioanalysis. 2018 Feb;10(4):205-214. doi: 10.4155/bio-2016-0292. Epub 2018 Jan 18.

PMID:
29345521
19.

Pharmacokinetics partly explains the relationship between carcinoembryonic antigen level and survival of colorectal cancer patients treated with ramucirumab.

Ibrahim S, Raoul W, Lecomte T, Paintaud G, Ternant D.

Eur J Cancer. 2018 Mar;92:119-120. doi: 10.1016/j.ejca.2017.12.004. Epub 2018 Jan 9. No abstract available.

20.

[Return to Work Strategies of Employees who Experienced Depression: Employers and HR's Perspectives].

Corbière M, Lecomte T, Lachance JP, Coutu MF, Negrini A, Laberon S.

Sante Ment Que. Fall 2017;42(2):173-196. French.

PMID:
29267420
21.
22.

Trastuzumab beyond progression in patients with HER2-positive advanced gastric adenocarcinoma: a multicenter AGEO study.

Palle J, Tougeron D, Pozet A, Soularue E, Artru P, Leroy F, Dubreuil O, Sarabi M, Williet N, Manfredi S, Martin-Babau J, Rebischung C, Abdelghani MB, Evesque L, Dreanic J, Hautefeuille V, Louafi S, Sefrioui D, Savinelli F, Mabro M, Rousseau B, Lecaille C, Bouché O, Louvet C, Lecomte T, Bonnetain F, Taieb J, Zaanan A.

Oncotarget. 2017 Sep 8;8(60):101383-101393. doi: 10.18632/oncotarget.20711. eCollection 2017 Nov 24.

23.

Model-Based Therapeutic Drug Monitoring of Infliximab Using a Single Serum Trough Concentration.

Ternant D, Passot C, Aubourg A, Goupille P, Desvignes C, Picon L, Lecomte T, Mulleman D, Paintaud G.

Clin Pharmacokinet. 2018 Sep;57(9):1173-1184. doi: 10.1007/s40262-017-0621-6.

PMID:
29236229
24.

Value of Contrast-Enhanced Ultrasound Quantification Criteria for Identifying Patients not Responding to Bevacizumab-Based Therapy for Colorectal Liver Metastases.

Tranquart F, Dujardin PA, Bouché O, Marcus C, Borg C, Manzoni P, Douillard JY, Labbe-Devilliers C, Terrebonne E, Smith D, Trillaud H, Capitain O, Aubé C, Spano JP, Lucidarme O, Ferru A, Tasu JP, Manfredi S, Bleuzen A, Léger J, Lecomte T.

Ultraschall Med. 2018 Oct;39(5):544-558. doi: 10.1055/s-0043-122497. Epub 2017 Dec 12.

PMID:
29232725
25.

Clinical outcome of portal vein thrombosis in patients with digestive cancers: A large AGEO multicenter study.

Regnault H, Emambux S, Lecomte T, Doat S, Dhooge M, Besson M, Dubreuil O, Moryoussef F, Silvain C, Bachet JB, Tougeron D.

Dig Liver Dis. 2018 Mar;50(3):285-290. doi: 10.1016/j.dld.2017.11.001. Epub 2017 Nov 16.

PMID:
29183764
26.

Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study.

Salimon M, Prieux-Klotz C, Tougeron D, Hautefeuille V, Caulet M, Gournay J, Matysiak-Budnik T, Bennouna J, Tiako Meyo M, Lecomte T, Zaanan A, Touchefeu Y.

Br J Cancer. 2018 Feb 6;118(3):325-330. doi: 10.1038/bjc.2017.413. Epub 2017 Nov 23.

PMID:
29169182
27.

Monoclonal Antibodies Targeting the IL-17/IL-17RA Axis: An Opportunity to Improve the Efficiency of Anti-VEGF Therapy in Fighting Metastatic Colorectal Cancer?

Ibrahim S, Girault A, Ohresser M, Lereclus E, Paintaud G, Lecomte T, Raoul W.

Clin Colorectal Cancer. 2018 Mar;17(1):e109-e113. doi: 10.1016/j.clcc.2017.10.003. Epub 2017 Oct 28. Review.

28.

Ca2+ protein alpha 1D of CaV1.3 regulates intracellular calcium concentration and migration of colon cancer cells through a non-canonical activity.

Fourbon Y, Guéguinou M, Félix R, Constantin B, Uguen A, Fromont G, Lajoie L, Magaud C, Lecomte T, Chamorey E, Chatelier A, Mignen O, Potier-Cartereau M, Chantôme A, Bois P, Vandier C.

Sci Rep. 2017 Oct 27;7(1):14199. doi: 10.1038/s41598-017-14230-1.

29.

Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results.

Aparicio T, Bouché O, Taieb J, Maillard E, Kirscher S, Etienne PL, Faroux R, Khemissa Akouz F, El Hajbi F, Locher C, Rinaldi Y, Lecomte T, Lavau-Denes S, Baconnier M, Oden-Gangloff A, Genet D, Paillaud E, Retornaz F, François E, Bedenne L; for PRODIGE 20 Investigators.

Ann Oncol. 2018 Jan 1;29(1):133-138. doi: 10.1093/annonc/mdx529.

30.

Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma.

Lièvre A, Ouine B, Canet J, Cartier A, Amar Y, Cacheux W, Mariani O, Guimbaud R, Selves J, Lecomte T, Guyetant S, Bieche I, Berger F, de Koning L.

Br J Cancer. 2017 Dec 5;117(12):1819-1827. doi: 10.1038/bjc.2017.353. Epub 2017 Oct 12. Erratum in: Br J Cancer. 2018 Aug;119(3):387.

31.

Acceptance and commitment therapy for psychosis and trauma: Improvement in psychiatric symptoms, emotion regulation, and treatment compliance following a brief group intervention.

Spidel A, Lecomte T, Kealy D, Daigneault I.

Psychol Psychother. 2018 Jun;91(2):248-261. doi: 10.1111/papt.12159. Epub 2017 Oct 4.

PMID:
28976056
32.

A serial mediation model of workplace social support on work productivity: the role of self-stigma and job tenure self-efficacy in people with severe mental disorders.

Villotti P, Corbière M, Dewa CS, Fraccaroli F, Sultan-Taïeb H, Zaniboni S, Lecomte T.

Disabil Rehabil. 2018 Dec;40(26):3113-3119. doi: 10.1080/09638288.2017.1377294. Epub 2017 Sep 12.

PMID:
28899202
33.

Canadian Treatment Guidelines on Psychosocial Treatment of Schizophrenia in Children and Youth.

Lecomte T, Abidi S, Garcia-Ortega I, Mian I, Jackson K, Jackson K, Norman R.

Can J Psychiatry. 2017 Sep;62(9):648-655. doi: 10.1177/0706743717720195. Review.

34.

Measurement of Telomere Length in Colorectal Cancers for Improved Molecular Diagnosis.

Balc'h EL, Grandin N, Demattei MV, Guyétant S, Tallet A, Pagès JC, Ouaissi M, Lecomte T, Charbonneau M.

Int J Mol Sci. 2017 Aug 29;18(9). pii: E1871. doi: 10.3390/ijms18091871.

35.

BioFlow: a non-invasive, image-based method to measure speed, pressure and forces inside living cells.

Boquet-Pujadas A, Lecomte T, Manich M, Thibeaux R, Labruyère E, Guillén N, Olivo-Marin JC, Dufour AC.

Sci Rep. 2017 Aug 23;7(1):9178. doi: 10.1038/s41598-017-09240-y.

36.

Canadian Guidelines for the Pharmacological Treatment of Schizophrenia Spectrum and Other Psychotic Disorders in Children and Youth.

Abidi S, Mian I, Garcia-Ortega I, Lecomte T, Raedler T, Jackson K, Jackson K, Pringsheim T, Addington D.

Can J Psychiatry. 2017 Sep;62(9):635-647. doi: 10.1177/0706743717720197. Epub 2017 Aug 2. Review.

37.

Symptom fluctuations, self-esteem, and cohesion during group cognitive behaviour therapy for early psychosis.

Lecomte T, Leclerc C, Wykes T.

Psychol Psychother. 2018 Mar;91(1):15-26. doi: 10.1111/papt.12139. Epub 2017 Jul 14.

PMID:
28707407
38.

Canadian Treatment Guidelines on Psychosocial Treatment of Schizophrenia in Adults.

Norman R, Lecomte T, Addington D, Anderson E.

Can J Psychiatry. 2017 Sep;62(9):617-623. doi: 10.1177/0706743717719894. Epub 2017 Jul 13. Review.

39.

Management of gastric neuro-endocrine tumours in a large French national cohort (GTE).

Manfredi S, Walter T, Baudin E, Coriat R, Ruszniewski P, Lecomte T, Laurenty AP, Goichot B, Rohmer V, Roquin G, Cojocarasu OZ, Lombard-Bohas C, Lepage C, Morcet J, Cadiot G.

Endocrine. 2017 Sep;57(3):504-511. doi: 10.1007/s12020-017-1355-9. Epub 2017 Jun 29.

40.

How Can Supervisors Contribute to the Return to Work of Employees Who have Experienced Depression?

Negrini A, Corbière M, Lecomte T, Coutu MF, Nieuwenhuijsen K, St-Arnaud L, Durand MJ, Gragnano A, Berbiche D.

J Occup Rehabil. 2018 Jun;28(2):279-288. doi: 10.1007/s10926-017-9715-0.

PMID:
28660364
41.

Narrative development and supported employment of persons with severe mental illness.

Cartwright KA, Lecomte T, Corbière M, Lysaker P.

J Ment Health. 2017 Jun 23:1-8. doi: 10.1080/09638237.2017.1340606. [Epub ahead of print]

PMID:
28644705
42.

Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort.

Walter T, Tougeron D, Baudin E, Le Malicot K, Lecomte T, Malka D, Hentic O, Manfredi S, Bonnet I, Guimbaud R, Coriat R, Lepère C, Desauw C, Thirot-Bidault A, Dahan L, Roquin G, Aparicio T, Legoux JL, Lombard-Bohas C, Scoazec JY, Lepage C, Cadiot G; CEPD investigators.

Eur J Cancer. 2017 Jul;79:158-165. doi: 10.1016/j.ejca.2017.04.009. Epub 2017 May 11.

PMID:
28501762
43.

Nab-paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil as first-line therapy for metastatic pancreatic adenocarcinoma (AFUGEM GERCOR): a non-comparative, multicentre, open-label, randomised phase 2 trial.

Bachet JB, Hammel P, Desramé J, Meurisse A, Chibaudel B, André T, Debourdeau P, Dauba J, Lecomte T, Seitz JF, Tournigand C, Aparicio T, Meyer VG, Taieb J, Volet J, Monier A, Bonnetain F, Louvet C.

Lancet Gastroenterol Hepatol. 2017 May;2(5):337-346. doi: 10.1016/S2468-1253(17)30046-8. Epub 2017 Feb 28.

PMID:
28397697
44.

A multicenter phase II study of personalized FOLFIRI-cetuximab for safe dose intensification.

Boisdron-Celle M, Metges JP, Capitain O, Adenis A, Raoul JL, Lecomte T, Lam YH, Faroux R, Masliah C, Poirier AL, Berger V, Morel A, Gamelin E.

Semin Oncol. 2017 Feb;44(1):24-33. doi: 10.1053/j.seminoncol.2017.02.007. Epub 2017 Feb 9.

PMID:
28395759
45.

One parasite may be hiding another...

Broutin L, Auzoux J, Anon B, Caulet M, Aubourg A, Lecomte T, Chandenier J, Desoubeaux G.

Ann Biol Clin (Paris). 2017 Apr 1;75(2):231-232. doi: 10.1684/abc.2017.1220. No abstract available.

PMID:
28377337
46.

A possible association of baseline serum IL-17A concentrations with progression-free survival of metastatic colorectal cancer patients treated with a bevacizumab-based regimen.

Lereclus E, Tout M, Girault A, Baroukh N, Caulet M, Borg C, Bouché O, Ternant D, Paintaud G, Lecomte T, Raoul W.

BMC Cancer. 2017 Mar 27;17(1):220. doi: 10.1186/s12885-017-3210-z.

47.

Predictors of Acquisition of Competitive Employment for People Enrolled in Supported Employment Programs.

Corbière M, Lecomte T, Reinharz D, Kirsh B, Goering P, Menear M, Berbiche D, Genest K, Goldner EM.

J Nerv Ment Dis. 2017 Apr;205(4):275-282. doi: 10.1097/NMD.0000000000000612.

PMID:
28212170
48.

Does personality influence job acquisition and tenure in people with severe mental illness enrolled in supported employment programs?

Fortin G, Lecomte T, Corbière M.

J Ment Health. 2017 Jun;26(3):248-256. doi: 10.1080/09638237.2016.1276534. Epub 2017 Jan 13.

PMID:
28084116
49.

Work Accommodations and Natural Supports for Employees with Severe Mental Illness in Social Businesses: An International Comparison.

Villotti P, Corbière M, Fossey E, Fraccaroli F, Lecomte T, Harvey C.

Community Ment Health J. 2017 Oct;53(7):864-870. doi: 10.1007/s10597-016-0068-5. Epub 2016 Dec 3.

PMID:
27913895
50.

Geriatric factors analyses from FFCD 2001-02 phase III study of first-line chemotherapy for elderly metastatic colorectal cancer patients.

Aparicio T, Gargot D, Teillet L, Maillard E, Genet D, Cretin J, Locher C, Bouché O, Breysacher G, Seitz JF, Gasmi M, Stefani L, Ramdani M, Lecomte T, Auby D, Faroux R, Bachet JB, Lepère C, Khemissa F, Sobhani I, Boulat O, Mitry E, Jouve JL; FFCD 2001-02 investigators.

Eur J Cancer. 2017 Mar;74:98-108. doi: 10.1016/j.ejca.2016.09.029. Epub 2016 Nov 5.

PMID:
27825697

Supplemental Content

Loading ...
Support Center